plays a physiological role for the regulation of luteal function during the estrous cycle.
(J. Reprod. Dev. 40 : 349-354, 1994) E pidermal growth factor (EGF) is a 53-residue acidic polypeptide (molecular weight 6045 daltons) which stimulates the proliferation of bovine, porcine, human and rodent granulosa cells [1] [2] [3] [4] . Aside from its mitogenic property, it is well demonstrated that EGF modulates several gonadotropin-related functions of granulosa cells; EGF inhibits follicle-stimulating hormone (FSH)-induced estrogen production by cultured rat granulosa cells [5] and FSH-mediated induction of luteinizing hormone receptors on rat granulosa cells [6] . The granulosa cells differentiate into luteal cells following ovulation, and the number of receptors for EGF on bovine luteal cells increases by severalfold compared to that on granulosa cells [1] . However, EGF does not exhibit any mitogenic effect on luteal cells [1, 7, 8] . Budnik corpus luteum changes during the estrous cycle. Furthermore, since the luteal receptor concentrations for oxytocin
[13] and prostaglandins [14] change during the estrous cycle, it is assumed that these substances play a physiological role in the corpus luteum as an autocrine or paracrine regulator. Although there are several reports describing the presence of receptors for EGF in bovine corpus luteum in pregnancy [1, 8, 15] , no systemic studies available on the expression of EGF or its receptors in bovine corpus luteum during the estrous cycle.
In the present study, therefore, the amounts of EGF and the characteristics of EGF receptors in corpus luteum during the estrous cycle were determined.
Materials and Methods
Bovine corpora lutea and human placenta Ovaries with corpus luteum from Holstein-Fresian cows were collected at a local slaughterhouse within 10-20 min after slaughter. The luteal phase was classified to early (3-5 days after ovulation), mid-(8-12 days after ovulation) and late (15-18 days after ovulation) stages by macroscopic observation of the ovary as described previously [16, 17] . After determination of the stages at the slaughterhouse, the corpora lutea were separated immediately from the ovaries, frozen rapidly in liquid nitrogen and then stored at -80 C until processed.
Human placenta was obtained just after a spon- (500 KIU/ml, Sigma) and 0.5 mM-phenylmethylsulfonyl fluoride (PMSF, Sigma), pH 7.4, and then homogenized in the same buffer with Polytron homogenizer (Kinematica, Lucerne, Switzerland) using two 10-sec bursts at full speed, separated by a 1-min cooling period in ice. For each luteal stage, three pools were prepared with each containing homogenates derived from 5 corpora lutea. The homogenates of luteal and placental tissue were subsequently centrifuged at 800 g for 10 min at 4 C. The supernatant including cell membranes was collected and centrifuged at 20,000 g for 20 min at 4 C. The pellet was resuspended in 25 mM-TrisHCl-buffer, pH 7.4, and centrifuged at 20,000 g for 10 min at 4 C. This was repeated three times and the final pellet was resuspended in the same buffer. The protein concentrations of the membrane preparations were determined by the method of Lowry et al. [19] using bovine serum albumin (BSA) as a standard.
The preparation was diluted to give the protein concentrations of 1 and 5 mg/ml for placenta villi and luteal membrane, respectively, with 25 mM-Tris-HC1-buffer containing 10 mMMgCl2 and 0.5 % (w/v) BSA, because our preliminary experiments showed enough binding for EGF with these protein concentrations to analyse the binding characteristics (data not shown). After that they were stored in 4 ml aliquots at -80 C until assayed. (Fig. 3 A, B, C) , thus indicating a single class of high-affinity binding sites.
Preparation of corpus luteum extracts
The affinity at mid luteal stage was significantly lower than at early stage (P<0.05, Table  1 ). There is no significant difference in the capacity of binding sites among three luteal stages (Table  1) .
EGF concentration in luteal tissue
As shown in Table 1 
